AK-7

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAK-7
Drug Alias NameSIRT-2 inhibitor (Massachusetts General Hospital)AK-7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-2 inhibitors
TargetsNAD-dependent protein deacetylase sirtuin-2
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe General Hospital Corporation D/B/A Massachusetts General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe General Hospital Corporation D/B/A Massachusetts General Hospital
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A